UnitedHealth Group (UNH)

Item 7.01 Regulation FD Disclosure.

On November 30, 2009, UnitedHealth Group Incorporated (the "Company") issued a press release announcing that it will host its annual investor conference with analysts and investors in New York City on Tuesday, December 1, 2009, beginning at 8:00 a.m. EST (the "Investor Conference"). A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

The Company will have an audio webcast of the Investor Conference on its Investors page at www.unitedhealthgroup.com. A replay of the Investor Conference will be available on the Company website through December 15, 2009. The slide book and the investor book containing answers to questions frequently asked by investors and related data about the Company's businesses will also be available on the Company's Investors page at www.unitedhealthgroup.com.

The information in this Item 7.01, including the exhibit attached hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any Company filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Exhibit Index

Item 7.01 Regulation FD Disclosure.

Senior members of UnitedHealth Group Incorporated's (the "Company") management team will appear at the Morgan Stanley Global Healthcare Unplugged Conference in New York, New York on September 15, 2009 at 8:00 a.m., Eastern Time. Management will answer investor questions about the Company's strategy and competitive position, as well as its performance in the first half of 2009. The Company will have an audio webcast of its presentation at the conference from the Investors page of its website at www.unitedhealthgroup.com.

The information in this Item 7.01 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any Company filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Item 7.01 Regulation FD Disclosure.

Senior members of UnitedHealth Group Incorporated's (the "Company") management team will be making a presentation at the Thirtieth Annual Goldman Sachs Global Healthcare Conference in New York, New York on June 10, 2009 at 9:00 a.m., Eastern Time. The presentation will focus on the Company's UnitedHealthcare business unit, including its customer value proposition and performance. The Company will have an audio webcast of its presentation at the conference from the Investors page of its website at www.unitedhealthgroup.com and will post a copy of the presentation on the Investors page of its website.

The information in this Item 7.01 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any Company filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Item 7.01 Regulation FD Disclosure.

Senior members of UnitedHealth Group Incorporated's (the "Company") management team will be making a presentation at the Sanford C. Bernstein 25th Annual Strategic Decisions Conference in New York, New York on May 29, 2009 at 9:00 a.m., Eastern Time. The presentation will focus on the Company's strategy and growth agenda in the context of the health care reform debate. The Company will have an audio webcast of its presentation at the conference from the Investors page of its website at www.unitedhealthgroup.com and will post a copy of the presentation on the Investors page of its website.

The information in this Item 7.01 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any Company filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Item 7.01 Regulation FD Disclosure.

Senior members of UnitedHealth Group Incorporated's (the "Company") management team will be making a presentation at the Deutsche Bank 34th Annual Health Care Conference in Boston, Massachusetts on May 19, 2009 at 7:30 a.m., Eastern Time. The presentation will focus on the Company's business strategy, including specific commentary about the Company's AmeriChoice business. The Company will have an audio webcast of its presentation at the conference from the Investors page of its website at www.unitedhealthgroup.com and will post a copy of the presentation on the Investors page of its website.

The information in this Item 7.01 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any Company filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Item 7.01 Regulation FD Disclosure.

Senior members of UnitedHealth Group Incorporated’s (the "Company") management team will be making a presentation at the 2009 Barclays Capital Global Healthcare Conference in Miami, Florida on March 10, 2009 at 9:00 a.m., Eastern Time. The presentation will focus on health care reform. The Company will have an audio webcast of its presentation at the conference from the Investors page of its website at www.unitedhealthgroup.com and will post a copy of the presentation on the Investors page of its website.

The information in this Item 7.01 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any Company filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Item 7.01 Regulation FD Disclosure.

Senior members of the Company’s management team will be making a presentation at the UBS 2009 Global Healthcare Services Conference in New York, New York on February 10, 2009 at 8:30 a.m., Eastern Time. The presentation will focus on the Company’s 2009 business outlook. The Company will have an audio webcast of its presentation at the conference from the Investors page of its website at www.unitedhealthgroup.com and will post a copy of the presentation on the Investors page of its website.

The information in this Item 7.01 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any Company filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Item 7.01 Regulation FD Disclosure.

Senior members of UnitedHealth Group Incorporated’s (the "Company") management team will be making a presentation at the 27th Annual JPMorgan Healthcare Conference in San Francisco, California on January 12, 2009 at 8:00 a.m., Pacific Time. The presentation will focus on healthcare reform. The Company will have an audio webcast of its presentation at the conference from the Investors page of its website at www.unitedhealthgroup.com. A replay of the Company’s presentation will be available on the Company website.

The information in this Item 7.01 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any Company filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Item 7.01 Regulation FD Disclosure.

Senior members of UnitedHealth Group Incorporated’s (the "Company") management team will be making an appearance and responding to audience questions at the Goldman Sachs CEOs Healthcare Conference in New York, New York on January 7, 2009 at 3:00 p.m., Eastern Time. The Company will have an audio webcast of its discussion at the conference from the Investors page of its website at www.unitedhealthgroup.com

The information in this Item 7.01 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any Company filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Item 7.01 Regulation FD Disclosure.

Senior members of UnitedHealth Group Incorporated's (the "Company") management team will be making an appearance and responding to audience questions at the Morgan Stanley Global Healthcare Unplugged Conference in New York, New York on September 9, 2008 at 9:45 a.m., Eastern Time. The Company will have an audio webcast of its discussion at the conference from the Investors page of its website at www.unitedhealthgroup.com.

The information in this Item 7.01 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any Company filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Item 7.01 Regulation FD Disclosure.

Senior members of UnitedHealth Group Incorporated's (the "Company") management team will be making a presentation at the Sanford C. Bernstein Strategic Decisions Conference in New York, New York on May 29, 2008 at 3:00 p.m., Eastern Time. The presentation will focus on the Company's publicly disclosed strategy of integrating capabilities and core businesses as a health system, and using that system to provide services to the broad health care marketplace. The Company will have an audio webcast of its presentation at the conference from the "Investor Information" section of its website at www.unitedhealthgroup.com. A replay of the Company's presentation will be available on the Company website.

The information in this Item 7.01 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any Company filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Item 7.01 Regulation FD Disclosure.

Senior members of UnitedHealth Group Incorporated's (the "Company") management team will be making a presentation at the Citi 2008 Global Healthcare Conference in New York, New York on May 21, 2008 at 8:00 a.m., Eastern Time. The presentation will focus on the Company's publicly disclosed business strategy, including specific commentary about the Company's AmeriChoice business. The Company will have an audio webcast of its presentation at the conference from the "Investor Information" section of its website at www.unitedhealthgroup.com. A replay of the Company's presentation will be available on the Company website.

The information in this Item 7.01 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any Company filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Item 7.01 Regulation FD Disclosure.

Senior members of UnitedHealth Group Incorporated's (the "Company") management team will be making a presentation at the Deutsche Bank 33rd Annual Health Care Conference in Boston, Massachusetts on May 6, 2008 at 2:50 p.m., Eastern Time. The presentation will focus on the Company's publicly disclosed business strategy, including specific commentary about the Company's Commercial Markets businesses. The Company will have an audio webcast of its presentation at the conference from the "Investor Information" section of its website at www.unitedhealthgroup.com. A replay of the Company's presentation will be available on the Company website.

The information in this Item 7.01 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any Company filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Item 7.01 Regulation FD Disclosure.

Senior members of UnitedHealth Group Incorporated’s (the "Company") management team will be making a presentation at the Lehman Brothers Eleventh Annual Global Healthcare Conference on March 18, 2008 at 8:00 a.m. (Eastern Time) in Miami, Florida. The presentation will focus on the Company's publicly disclosed business strategy, including specific commentary about the Company's Ingenix businesses. The Company will have an audio webcast of its presentation at the conference from the "Lehman Brothers Eleventh Annual Global Healthcare Conference" section of the Company's "Investor Information" page at www.unitedhealthgroup.com. A replay of the Company's presentation will be available on the Company website.

The information in this Item 7.01 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any Company filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Item 7.01 Regulation FD Disclosure.

On March 12, 2008, UnitedHealth Group Incorporated (the "Company") issued a press release, a copy of which is furnished herewith as Exhibit 99.1 and is incorporated in this Item 7.01 by reference.

The information in this Item 7.01 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any Company filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

Item 7.01 Regulation FD Disclosure.

From time to time through the balance of February 2008, senior members of UnitedHealth Group Incorporated's (the "Company") management team will be meeting with investors and analysts. Those discussions will focus on the Company's publicly disclosed business strategy. During these meetings, the Company also expects to reaffirm its publicly disclosed financial expectations for full year 2008.

The information in this Item 7.01 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any Company filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Item 7.01 Regulation FD Disclosure.

Senior members of UnitedHealth Group Incorporated's (the "Company") management team will be making a presentation at the UBS Global Healthcare Services Conference on February 12, 2008 at 12:00 p.m. Eastern Time. The presentation will focus on the Company's publicly disclosed business strategy, including specific commentary about the Company’s public and senior market businesses. The Company will have an audio webcast of its presentation at the conference from the "UBS Global Healthcare Services Conference" section of the Company's "Investor Information" page at www.unitedhealthgroup.com. A replay of the Company’s presentation will be available on the Company website.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Item 7.01 Regulation FD Disclosure.

On December 3, 2007, UnitedHealth Group Incorporated (the "Company") issued a press release announcing that it will host its annual investor conference with institutional analysts and investors in New York City on Tuesday December 4, 2007, beginning at 8:00 a.m. EST ("Investor Conference"). A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

The Company will have an audio webcast of the Investor Conference on the Investor Conference section of its Investor Information page at www.unitedhealthgroup.com. A replay of the Investor Conference will be available on the Company Web site through December 18, 2007. The slide book and the investor book containing answers to questions frequently asked by investors and related data about the Company's businesses will also be available on the Investor Conference section of the Company's Investor Information page at www.unitedhealthgroup.com.

In addition, during the fourth quarter of 2007, the Company completed the transition to its new segment reporting structure and will begin reporting on this basis in its Annual Report on Form 10-K for the fiscal year ending December 31, 2007 (the "2007 10-K"). The reporting structure will have four segments: Health Care Services, Prescription Solutions, OptumHealth and Ingenix. The segment information contained in the slide book and the investor book reflects the Company's new segments to be reported in its 2007 10-K. Such new segment information is provided supplementally to investors to improve the comparability of the Company's results between periods.

The information in this Item 7.01, including the exhibit attached hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any Company filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

Item 7.01 Regulation FD Disclosure.

Senior members of UnitedHealth Group Incorporated's (the "Company") management team will be making a presentation at the Bear Stearns 20th Annual Healthcare Conference (the "Bear Stearns Conference") on September 10, 2007 at 3:00 p.m., Eastern Time. The Company will have an audio webcast of its presentation at the Bear Stearns Conference from the "Investor Information" section of its website at www.unitedhealthgroup.com. The Company also will post a copy of the presentation on the "Investor Information" section of its website on September 10, 2007. A replay of the Company’s presentation will be available on the Company website through October 9, 2007.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Item 7.01 Regulation FD Disclosure.

The second quarter 2007 Form 10-Q filed by UnitedHealth Group Incorporated (the "Company") today reflected the following information. On July 27, 2007, the Company was informed by the Centers for Medicare and Medicaid Services (CMS) of final favorable adjustments related to its 2006 Medicare business. Given this timing, the Company is required under GAAP to reflect this in its second quarter results.

Accordingly, final second quarter 2007 results for UnitedHealth Group improved two cents per share compared with the preliminary results reported in the Company's press release issued on July 19, 2007. Second quarter consolidated net earnings are $1.228 billion, or $0.89 per share, which were preliminarily reported as net earnings of $1.197 billion, or $0.87 per share.

As a result of this development, the Company is increasing its full year 2007 earnings outlook to a range of $3.45 to $3.50 per share, excluding $0.08 in Section 409A charges related to historic stock option matters. Third quarter earnings continue to be expected to be in the range of $0.91 to $0.93 per share. The Company anticipates that full year reported earnings will be in the range of $3.37 to $3.42 per share, including first quarter 409A charges.

From time to time through the balance of August 2007 and the first half of September 2007, senior members of the Company's management team will be meeting with investors and analysts. Those discussions will focus on the Company's publicly disclosed business strategy and will include a reaffirmation of the Company's publicly disclosed financial expectations, as discussed above.

CAUTIONARY STATEMENT FOR PURPOSES OF THE "SAFE HARBOR" PROVISIONS OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

UnitedHealth Group and its representatives may from time to time make written and oral forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (PSLRA), including statements in this report, in presentations, press releases, filings with the Securities and Exchange Commission, reports to shareholders and in meetings with analysts and investors. Generally the words "believe," "expect," "intend," "estimate," "anticipate," "plan," "project," "will" and similar expressions, identify forward-looking statements, which generally are not historical in nature. These statements may contain information about financial prospects, economic conditions, trends and unknown certainties. We caution that actual results could differ materially from those that management expects, depending on the outcome of certain factors. These forward-looking statements involve risks and uncertainties that may cause UnitedHealth Group's actual results to differ materially from the results discussed in the forward-looking statements. Some factors that could cause results to differ materially from the forward-looking statements include: the potential consequences of the findings announced on October 15, 2006 of the investigation by an Independent Committee of directors of our historic stock option practices, the consequences of the restatement of our previous financial statements, related governmental reviews, including a formal investigation by the SEC, and review by the IRS, U.S. Congressional committees, U.S. Attorney for the Southern District of New York and Minnesota Attorney General, a related review by the Special Litigation Committee of the Company, and related shareholder derivative actions, shareholder demands and purported securities and Employee Retirement Income Security Act (ERISA) class actions, the resolution of matters currently subject to an injunction issued by the United States District Court for the District of Minnesota, a purported notice of acceleration with respect to certain of the Company's debt securities based upon an alleged event of default under the indenture governing such securities, and recent management and director changes, and the potential impact of each of these matters on our business, credit ratings and debt; increases in health care costs that are higher than we anticipated in establishing our premium rates, including increased consumption of or costs of medical services; heightened competition as a result of new entrants into our market, and consolidation of health care companies and suppliers; events that may negatively affect our contract with AARP; uncertainties regarding changes in Medicare, including coordination of information systems and accuracy of certain assumptions; funding risks with respect to revenues received from Medicare and Medicaid programs; increases in costs and other liabilities associated with increased litigation, legislative activity and government regulation and review of our industry; our ability to execute contracts on competitive terms with physicians, hospitals and other service providers; regulatory and other risks associated with the pharmacy benefits management industry; failure to maintain effective and efficient information systems, which could result in the loss of existing customers, difficulties in attracting new customers, difficulties in determining medical costs estimates and appropriate pricing, customer and physician and health care provider disputes, regulatory violations, increases in operating costs, or other adverse consequences; possible impairment of the value of our intangible assets if future results do not adequately support goodwill and intangible assets recorded for businesses that we acquire; potential noncompliance by our business associates with patient privacy data; misappropriation of our proprietary technology; and anticipated benefits of acquisitions that may not be realized.

This list of important factors is not intended to be exhaustive. A further list and description of some of these risks and uncertainties can be found in our reports filed with the Securities and Exchange Commission from time to time, including annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. Any or all forward-looking statements we make may turn out to be wrong. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. Except to the extent otherwise required by federal securities laws, we do not undertake to publicly update or revise any forward-looking statements.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Item 7.01 Regulation FD Disclosure.

From time to time in the second half of May 2007 and the first half of June 2007, Stephen J. Hemsley, President and Chief Executive Officer of UnitedHealth Group Incorporated (the "Company"), and other senior members of the Company's management team will be meeting with investors and analysts, including making a presentation at the Sanford C. Bernstein Strategic Decisions Conference (the "Bernstein Conference") on May 31, 2007. Those discussions will focus on the Company's publicly disclosed business strategy and will include a reaffirmation of the Company's publicly disclosed financial expectations.

The Company will have an audio webcast of its presentation at the Bernstein Conference from the "Investor Information" section of its website at www.unitedhealthgroup.com. The Company also will post a copy of the presentation on the "Investor Information" section of its website on May 31, 2007. A replay of the Company’s presentation will be available on the Company website through June 30, 2007.

CAUTIONARY STATEMENT FOR PURPOSES OF THE "SAFE HARBOR" PROVISIONS OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

UnitedHealth Group and its representatives may from time to time make written and oral forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (PSLRA), including statements in this report, in presentations, press releases, filings with the Securities and Exchange Commission, reports to shareholders and in meetings with analysts and investors. Generally the words "believe," "expect," "intend," "estimate," "anticipate," "plan," "project," "will" and similar expressions, identify forward-looking statements, which generally are not historical in nature. These statements may contain information about financial prospects, economic conditions, trends and unknown certainties. We caution that actual results could differ materially from those that management expects, depending on the outcome of certain factors. These forward-looking statements involve risks and uncertainties that may cause UnitedHealth Group's actual results to differ materially from the results discussed in the forward-looking statements. Some factors that could cause results to differ materially from the forward-looking statements include: the potential consequences of the findings announced on October 15, 2006 of the investigation by an Independent Committee of directors of our historic stock option practices, the consequences of the restatement of our previous financial statements, related governmental reviews, including a formal investigation by the SEC, and review by the IRS, U.S. Congressional committees, U.S. Attorney for the Southern District of New York and Minnesota Attorney General, a related review by the Special Litigation Committee of the Company, and related shareholder derivative actions, shareholder demands and purported securities and Employee Retirement Income Security Act (ERISA) class actions, the resolution of matters currently subject to an injunction issued by the United States District Court for the District of Minnesota, a purported notice of acceleration with respect to certain of the Company’s debt securities based upon an alleged event of default under the indenture governing such securities, and recent management and director changes, and the potential impact of each of these matters on our business, credit ratings and debt; increases in health care costs that are higher than we anticipated in establishing our premium rates, including increased consumption of or costs of medical services; heightened competition as a result of new entrants into our market, and consolidation of health care companies and suppliers; events that may negatively affect our contract with AARP; uncertainties regarding changes in Medicare, including coordination of information systems and accuracy of certain assumptions; funding risks with respect to revenues received from Medicare and Medicaid programs; increases in costs and other liabilities associated with increased litigation, legislative activity and government regulation and review of our industry; our ability to execute contracts on competitive terms with physicians, hospitals and other service providers; regulatory and other risks associated with the pharmacy benefits management industry; failure to maintain effective and efficient information systems, which could result in the loss of existing customers, difficulties in attracting new customers, difficulties in determining medical costs estimates and appropriate pricing, customer and physician and health care provider disputes, regulatory violations, increases in operating costs, or other adverse consequences; possible impairment of the value of our intangible assets if future results do not adequately support goodwill and intangible assets recorded for businesses that we acquire; potential noncompliance by our business associates with patient privacy data; misappropriation of our proprietary technology; and anticipated benefits of acquisitions that may not be realized.

This list of important factors is not intended to be exhaustive. A further list and description of some of these risks and uncertainties can be found in our reports filed with the Securities and Exchange Commission from time to time, including annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. Any or all forward-looking statements we make may turn out to be wrong. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. Except to the extent otherwise required by federal securities laws, we do not undertake to publicly update or revise any forward-looking statements.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Item 7.01 Regulation FD Disclosure.

On February 5, 2007, UnitedHealth Group Incorporated (the "Company") issued a press release announcing a revised 2007 revenue outlook for its Ovations business. A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated in this Item 7.01 by reference.

CAUTIONARY STATEMENT FOR PURPOSES OF THE "SAFE HARBOR" PROVISIONS OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

UnitedHealth Group and its representatives may from time to time make written and oral forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (PSLRA), including statements in this report, in presentations, press releases, filings with the Securities and Exchange Commission, reports to shareholders and in meetings with analysts and investors. Generally the words "believe," "expect," "intend," "estimate," "anticipate," "project," "will" and similar expressions, identify forward-looking statements, which generally are not historical in nature. These statements may contain information about financial prospects, economic conditions, trends and unknown certainties. We caution that actual results could differ materially from those that management expects, depending on the outcome of certain factors. These forward-looking statements involve risks and uncertainties that may cause our actual results to differ materially from the results discussed in the forward-looking statements. Some factors that could cause results to differ materially from the forward-looking statements include: the potential consequences of the findings announced on October 15, 2006 of the investigation by an Independent Committee of directors of our stock option programs (including the consequences of our determination that the Company’s financial statements for the years ended 1994 to 2005, the interim periods contained therein, the quarter ended March 31, 2006 and all earnings and press releases, including for the quarters ended June 30, 2006 and September 30, 2006, and similar communications issued by the Company for such periods and the related reports of the Company’s independent registered public accounting firm should not be relied upon, the consequences of the resulting restatement of our financial statements for those periods, and delays in filing our quarterly reports on Form 10-Q for the second and third quarters of 2006), related governmental reviews, including a formal investigation by the SEC, and review by the IRS, U.S. Senate Finance Committee, U.S. Attorney for the Southern District of New York and Minnesota Attorney General, a related review by the Special Litigation Committee of the Company, and related shareholder derivative actions, shareholder demands and purported securities and Employee Retirement Income Security Act (ERISA) class actions, the resolution of matters currently subject to an injunction issued by the United States District Court for the District of Minnesota, a purported notice of acceleration with respect to certain of the Company’s debt securities based upon an alleged event of default under the indenture governing such securities, and recent management and director changes, and the potential impact of each of these matters on our business, credit ratings and debt; increases in health care costs that are higher than we anticipated in establishing our premium rates, including increased consumption of or costs of medical services; heightened competition as a result of new entrants into our market, and consolidation of health care companies and suppliers; events that may negatively affect our contract with AARP; uncertainties regarding changes in Medicare, including coordination of information systems and accuracy of certain assumptions; funding risks with respect to revenues received from Medicare and Medicaid programs; increases in costs and other liabilities associated with increased litigation, legislative activity and government regulation and review of our industry; our ability to execute contracts on competitive terms with physicians, hospitals and other service providers; regulatory and other risks associated with the pharmacy benefits management industry; failure to maintain effective and efficient information systems, which could result in the loss of existing customers, difficulties in attracting new customers, difficulties in determining medical costs estimates and appropriate pricing, customer and physician and health care provider disputes, regulatory violations, increases in operating costs, or other adverse consequences; possible impairment of the value of our intangible assets if future results do not adequately support goodwill and intangible assets recorded for businesses that we acquire; potential noncompliance by our business associates with patient privacy data; misappropriation of our proprietary technology; and anticipated benefits of acquiring PacifiCare that may not be realized.

This list of important factors is not intended to be exhaustive. A further list and description of some of these risks and uncertainties can be found in our reports filed with the Securities and Exchange Commission from time to time, including our annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. Any or all forward-looking statements we make may turn out to be wrong. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. Except to the extent otherwise required by federal securities laws, we do not undertake to publicly update or revise any forward-looking statements.

Item 7.01 Regulation FD Disclosure.

On January 10, 2007, UnitedHealth Group Incorporated (the "Company") will make a presentation to institutional investors at the JPMorgan Health Care Conference. During this presentation, the Company's chief executive officer and president, Stephen J. Hemsley, will review the Company's publicly disclosed business strategy, as well as reaffirm its previous financial outlook ranges for 2006 and 2007 discussed at its Investor Conference on December 19, 2006.

The Company notes that these outlooks reflect management's estimates of the range of additional non-cash charges for stock-based compensation expense for the applicable period arising from the review of the Company’s historical stock option practices conducted by an Independent Committee of the Board of Directors of the Company. These estimates are not yet final and are subject to change based upon the finalization of the Company’s restatement of its historical financial statements. These outlooks also exclude any adjustment for any non-operating cash charges which may be required in connection with the resolution of stock option-related tax matters, litigation, and regulatory matters, the amount and timing of which are uncertain but which are likely to be material.

The Company will have an audio webcast of its presentation from the "Investor Information" section of its website at www.unitedhealthgroup.com. The Company will post a copy of the presentation on the "Investor Information" section of its website and will file a current report on Form 8-K with the Securities and Exchange Commission to furnish a copy of the presentation.

CAUTIONARY STATEMENTS FOR PURPOSES OF THE "SAFE HARBOR" PROVISIONS OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

UnitedHealth Group and its representatives may from time to time make written and oral forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (PSLRA), including statements in this report, in presentations, press releases, filings with the Securities and Exchange Commission, reports to shareholders and in meetings with analysts and investors. Generally the words "believe," "expect," "intend," "estimate," "anticipate," "project," "will" and similar expressions, identify forward-looking statements, which generally are not historical in nature. These statements may contain information about financial prospects, economic conditions, trends and unknown certainties. We caution that actual results could differ materially from those that management expects, depending on the outcome of certain factors. These forward-looking statements involve risks and uncertainties that may cause our actual results to differ materially from the results discussed in the forward-looking statements. Some factors that could cause results to differ materially from the forward-looking statements include: the potential consequences of the findings announced on October 15, 2006 of the investigation by an Independent Committee of directors of our stock option programs (including the consequences of our determination that the Company's financial statements for the years ended 1994 to 2005, the interim periods contained therein, the quarter ended March 31, 2006 and all earnings and press releases, including for the quarters ended June 30, 2006 and September 30, 2006, and similar communications issued by the Company for such periods and the related reports of the Company's independent registered public accounting firm should not be relied upon, the consequences of the resulting restatement of our financial statements for those periods, and delays in filing our quarterly reports on Form 10-Q for the second and third quarters of 2006), related governmental reviews, including a formal investigation by the SEC, and review by the IRS, U.S. Senate Finance Committee, U.S. Attorney for the Southern District of New York and Minnesota Attorney General, a related review by the Special Litigation Committee of the Company, and related shareholder derivative actions, shareholder demands and purported securities class actions, the resolution of matters currently subject to an injunction issued by the United States District Court for the District of Minnesota, a purported notice of acceleration with respect to certain of the Company’s debt securities based upon an alleged event of default under the indenture governing such securities, and recent management and director changes, and the potential impact of each of these matters on our business, credit ratings and debt; increases in health care costs that are higher than we anticipated in establishing our premium rates, including increased consumption of or costs of medical services; heightened competition as a result of new entrants into our market, and consolidation of health care companies and suppliers; events that may negatively affect our contract with AARP; uncertainties regarding changes in Medicare, including coordination of information systems and accuracy of certain assumptions; funding risks with respect to revenues received from Medicare and Medicaid programs; increases in costs and other liabilities associated with increased litigation, legislative activity and government regulation and review of our industry; our ability to execute contracts on competitive terms with physicians, hospitals and other service providers; regulatory and other risks associated with the pharmacy benefits management industry; failure to maintain effective and efficient information systems, which could result in the loss of existing customers, difficulties in attracting new customers, difficulties in determining medical costs estimates and appropriate pricing, customer and physician and health care provider disputes, regulatory violations, increases in operating costs, or other adverse consequences; possible impairment of the value of our intangible assets if future results do not adequately support goodwill and intangible assets recorded for businesses that we acquire; potential noncompliance by our business associates with patient privacy data; misappropriation of our proprietary technology; and anticipated benefits of acquiring PacifiCare that may not be realized.

This list of important factors is not intended to be exhaustive. A further list and description of some of these risks and uncertainties can be found in our reports filed with the Securities and Exchange Commission from time to time, including our annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. Any or all forward-looking statements we make may turn out to be wrong. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. Except to the extent otherwise required by federal securities laws, we do not undertake to publicly update or revise any forward-looking statements.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.